Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness
Lawrence J. Hayward, Joanna S. Kim, Ming-Yang Lee, Hongru Zhou, Ji W. Kim, Kumudini Misra, Mohammad Salajegheh, Fen-fen Wu, Chie Matsuda, Valerie Reid, Didier Cros, Eric P. Hoffman, Jean-Marc Renaud, Stephen C. Cannon, Robert H. Brown Jr.
Lawrence J. Hayward, Joanna S. Kim, Ming-Yang Lee, Hongru Zhou, Ji W. Kim, Kumudini Misra, Mohammad Salajegheh, Fen-fen Wu, Chie Matsuda, Valerie Reid, Didier Cros, Eric P. Hoffman, Jean-Marc Renaud, Stephen C. Cannon, Robert H. Brown Jr.
View: Text | PDF
Research Article Muscle biology

Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness

  • Text
  • PDF
Abstract

Hyperkalemic periodic paralysis (HyperKPP) produces myotonia and attacks of muscle weakness triggered by rest after exercise or by K+ ingestion. We introduced a missense substitution corresponding to a human familial HyperKPP mutation (Met1592Val) into the mouse gene encoding the skeletal muscle voltage-gated Na+ channel NaV1.4. Mice heterozygous for this mutation exhibited prominent myotonia at rest and muscle fiber-type switching to a more oxidative phenotype compared with controls. Isolated mutant extensor digitorum longus muscles were abnormally sensitive to the Na+/K+ pump inhibitor ouabain and exhibited age-dependent changes, including delayed relaxation and altered generation of tetanic force. Moreover, rapid and sustained weakness of isolated mutant muscles was induced when the extracellular K+ concentration was increased from 4 mM to 10 mM, a level observed in the muscle interstitium of humans during exercise. Mutant muscle recovered from stimulation-induced fatigue more slowly than did control muscle, and the extent of recovery was decreased in the presence of high extracellular K+ levels. These findings demonstrate that expression of the Met1592Val Na+ channel in mouse muscle is sufficient to produce important features of HyperKPP, including myotonia, K+-sensitive paralysis, and susceptibility to delayed weakness during recovery from fatigue.

Authors

Lawrence J. Hayward, Joanna S. Kim, Ming-Yang Lee, Hongru Zhou, Ji W. Kim, Kumudini Misra, Mohammad Salajegheh, Fen-fen Wu, Chie Matsuda, Valerie Reid, Didier Cros, Eric P. Hoffman, Jean-Marc Renaud, Stephen C. Cannon, Robert H. Brown Jr.

×

Figure 8

Mutant (+/m) EDL fatigued more slowly than control (+/+) muscle and was more vulnerable to impaired recovery in elevated [K+]o.

Options: View larger image (or click on image) Download as PowerPoint
Mutant (+/m) EDL fatigued more slowly than control (+/+) muscle and was ...
(A–C) Fatigue was induced by continuous 100-Hz stimulation to isolated EDL muscles using 1-ms pulses in bath that contained 4 mM [K+] and 2 mM [Ca2+]. (A) In the left panel, tetanic force was normalized to the peak value, and the responses (mean ± SD, dashed lines) are shown for EDL from (+/m) mice (n = 8, 10.8 ± 2.2 months old) or (+/+) mice (n = 5, 11.4 ± 1.8 months old). The time required for decline to 50% of the peak force (fatigue T1/2R) was increased by 2.3-fold for the older mutant mice versus controls and by 1.8-fold for younger mutant mice (n = 6, 4.0 ± 0.7 months old) versus controls (n = 10, 4.2 ± 0.8 months old). (B) Recovery from fatigue for EDL muscles from 8.5 ± 0.4–month-old mutant (n = 6) and sibling controls (n = 5) in normal [K+]. Tetanic stimuli (0.5-ms, 70-mA current pulses for 300 ms at 125 Hz) were applied before and after 100-Hz stimulation (small blue box), and the normalized responses (mean ± SEM) are shown. The time required to regain 50% of the full extent of recovery (recovery T1/2R) was increased by 2.8-fold for mutant compared with control. (C) Stimulation of EDL muscles to fatigue as in B was followed by exposure to a bath containing 10 mM [K+] and 0.5 mM [Ca2+], which impaired the extent of recovery for mutant more than control muscles. Weakness was reversible in recovery buffer, and mutant muscles regained force 1.9-fold faster than did control muscle. Gray bars in the left panels indicate significant differences by ANOVA (P < 0.05) between mutant (red circles) and control (open squares) responses. The bar graphs in the right panels show mean ± SEM. *P < 0.005, 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts